Echelon Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Echelon Biosciences's estimated annual revenue is currently $2M per year.
- Echelon Biosciences's estimated revenue per employee is $155,000
Employee Data
- Echelon Biosciences has 13 Employees.
- Echelon Biosciences grew their employee count by 8% last year.
Echelon Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | COO | Reveal Email/Phone |
2 | VP R&D | BD | Reveal Email/Phone |
3 | Production and Quality Assurance Manager | Reveal Email/Phone |
4 | Dir Applied Tech | Reveal Email/Phone |
5 | Dir Accounting/HR | Reveal Email/Phone |
6 | Scientist | Reveal Email/Phone |
7 | Scientist | Reveal Email/Phone |
Echelon Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | -17% | N/A | N/A |
#2 | $1.4M | 9 | -10% | N/A | N/A |
#3 | $5.9M | 38 | 41% | N/A | N/A |
#4 | $1.1M | 7 | -53% | N/A | N/A |
#5 | $1.6M | 10 | 11% | N/A | N/A |
#6 | $21.2M | 137 | 10% | N/A | N/A |
#7 | $1.6M | 33 | -48% | $17.8M | N/A |
#8 | $1.9M | 12 | 0% | N/A | N/A |
#9 | $3.7M | 24 | 9% | N/A | N/A |
#10 | $0.9M | 6 | 0% | N/A | N/A |
What Is Echelon Biosciences?
At Echelon, our goal is to be a global leader in supplying biochemical reagents, assays, and screening services to further academic research and pharmaceutical development. Echelon has always been committed to making, testing, and supporting quality reagents and providing superior service. We value integrity in business and strive to keep our focus on our customer’s needs so they can continue to do incredible research!
keywords:N/AN/A
Total Funding
13
Number of Employees
$2M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 13 | -58% | N/A |
#2 | $1.6M | 13 | 8% | N/A |
#3 | $1.6M | 13 | 8% | N/A |
#4 | $1.7M | 13 | -38% | N/A |
#5 | $35M | 13 | 0% | N/A |